eFFECTOR Therapeutics, Inc. (EFTR)
(Delayed Data from NSDQ)
$1.31 USD
-0.07 (-5.07%)
Updated Jun 7, 2024 03:59 PM ET
After-Market: $1.31 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
F Value B Growth A Momentum C VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 33% (83 out of 248)Zacks Sector Rank
Top 50% (8 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.00 | 1.35 | 9.99 |
Current Quarter Estimate | -1.74 | 2.87 | 57.00 |
Year Ago Quarter Estimate | -4.25 | -5.36 | 52.54 |
Next Quarter Estimate | -1.54 | 7.43 | 61.00 |
Next Year Estimate | -2.25 | 37.76 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 65.61 | 15.40 | 15.67 |
Next Year | 60.04 | 9.00 | 9.31 |
Last 5 Years | NA | 1.00 | 8.10 |
Next 5 Years | NA | 20.80 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -2.18 |
Price/Book (MRQ) | 6.51 | 2.15 |
Price/Cash Flow (MRFY) | NA | 17.00 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | NA | -164.45% |
Return on Equity (TTM) | NA | -59.04% |
Debt to Equity (MRQ) | 0.00 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.